Who owns CONNECT BIOPHARMA HLDGS LTD?
- CUSIP Number: g23549101
Tip: Access positions for across all investors
Analyze quarterly positions in Connect Biopharma Hldgs with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Connect Biopharma Hldgs stock
Who bought or sold CONNECT BIOPHARMA HLDGS LTD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BML Capital Management | 1.3M | $1.9M | 100% | Sep 2025 |
|
| Renaissance Technologies | 158k | $239k | 100% | Sep 2025 |
|
| Marshall Wace | 58k | $86k | 100% | Sep 2025 |
|
| Koa Wealth Management | 50k | $75k | 100% | Sep 2025 |
|
| XTX Topco | 24k | $35k | 100% | Sep 2025 |
|
| Geode Capital Management | 23k | $35k | 100% | Sep 2025 |
|
| Susquehanna International | 14k | $20k | 100% | Sep 2025 |
|
| Monograph Wealth Advisors | 11k | $17k | 100% | Sep 2025 |
|
| Hrt Financial | 11k | $15k | 100% | Sep 2025 |
|
| Rhumbline Advisers | 780.00 | $1.2k | 100% | Sep 2025 |
|
| UBS Group | 201.00 | $303.992400 | 100% | Sep 2025 |
|
| Jpmorgan Chase & Co | 121.00 | $178.995300 | 100% | Sep 2025 |
|
| SBI Securities | 7.00 | $10.999800 | 100% | Sep 2025 |
|